Human papillomavirus (HPV) testing is used in the triage of women with a borderline smear
result. The efficiency of testing women with a low-grade squamous intraepithelial lesion …

OBJECTIVE: We evaluated high-risk human papillomavirus (HPV) testing by Hybrid Capture
II (HC II) in addition to cytology to predict recurrent/residual cervical intraepithelial neoplasia …

OBJECTIVE: To determine the absolute risk of cervical intraepithelial neoplasia (CIN) grade
3 or cervical cancer (CIN 3 or worse) after detection of low-risk human papillomavirus (HPV) …

Background: In many low-resource settings, there are barriers to cytologic screening for
cervical cancer. This study evaluates human papillomavirus (HPV) DNA testing as an …

The indications for colposcopy have changed recently because of the new Bethesda
terminology, the introduction of HPV testing in clinical practice, and the latest consensus …

The most compelling question in evaluating the possible replacement of the conventional
Papanicolaou smear from a high‐risk HPV testing method is the balance between specificity …

Context.—The limitations of newer cervical screening tests are still being studied. Objective.—
To investigate those limitations, we conducted a retrospective review of 287 cases of …

Importance There is limited information about the relative effectiveness of cervical cancer
screening with primary human papillomavirus (HPV) testing alone compared with cytology in …

Background Human papillomavirus (HPV) testing is known to be more sensitive, but less
specific than cytology for detecting cervical intraepithelial neoplasia (CIN). We assessed the …

Background: Although testing for human papillomavirus (HPV) has higher sensitivity and
lower specificity than cytology alone for detecting cervical intraepithelial neoplasia (CIN) …